August 11, 2015
On July 21, 2016, Gov. Hassan signed HB 508 into law. The new law applies to group health policies that provide coverage for anti-cancer medications. Insurers are prohibited from imposing a higher deductible, copayment or coinsurance amount for patient-administered medications than for injected or intravenously administered medications. This applies regardless of the plan’s drug formulary or benefit category determination. The law is effective for plan years starting on or after Jan. 1, 2017.
HB 508 »